Search Results
481 Results
“I saw NIAID’s DEIA request for information, but I think I answered one of those already?”
Funding News Edition: March 1, 2023
Reviewing NIAID’s Application and Award Counts for FY 2022
Funding News Edition: February 15, 2023
We share the number of R01-equivalent and R21 applications that NIAID received in the previous fiscal year (FY) as well as how many awards NIAID made in turn.
New Initiative Focuses on Food Allergy Research
Funding News Edition: February 15, 2023
NIAID established the clinical trial network Consortium for Food Allergy Research to address concerns about the increasing incidence of food allergy and paucity of treatment options.
Administrative Supplement Supports Research Testing on Gender Measurement
Funding News Edition: February 15, 2023
The health conditions of interest to NIAID impact the health of sexual minority and majority populations, and the Institute endorses meaningful sexual orientation and gender identity measurement in research, clinical care, and administrative settings.
Contribute to NIAID’s Efforts on Diversity, Equity, Inclusion, and Accessibility (DEIA)
Funding News Edition: February 15, 2023
NIAID invites information and recommendations to enhance DEIA across the Institute’s funded activities, such as strategies to address any systematic and structural barriers to receiving NIAID research funding that may exist.
Prepare Your First Data Management and Sharing Plan
Funding News Edition: February 15, 2023
Start with NIH’s extensive guidance; a new page features sample data management and sharing plans and the frequently asked questions page explains how to account for data management and sharing in your budget.
International Awards—Part I. Determining Eligibility
Funding News Edition: February 15, 2023
The eligibility of a principal investigator differs from that of an institution. This is important in the context of fellowships and career development awards, where non-citizens may be working at U.S. institutions, or U.S. citizens may be working at international institutions.
“Does NIAID include not discussed applications in the percentile calculation?”
Funding News Edition: February 15, 2023
NIAID-Supported HIV Vaccine Trials Network Has New Specimens Available
Funding News Edition: February 15, 2023
The HIV Vaccine Trials Network (HVTN) invites outside investigators to apply to use Imbokodo/HVTN 705 participant specimens or study data to conduct independent scientific research. Respond by April 4, 2023.
Summary of January 2023 Advisory Council Meeting
Funding News Edition: February 15, 2023
NIAID Acting Director Dr. Hugh Auchincloss provided updates on HIV/AIDS, malaria, Ebola, a promising Marburg vaccine, universal flu vaccine efforts, non-viral asthma attacks, monoclonal antibodies to target Epstein-Barr virus, and human antibody response to vaccinations.
Appreciation for 2022 NIAID Peer Review and Committee Volunteers
Funding News Edition: February 1, 2023
On behalf of NIAID and our research community, we express our deepest gratitude to fiscal year 2022 review and advisory group volunteers for donating their precious time and effort.
Four Research Areas Comprise NIAID’s 2023 Omnibus Contract Solicitation
Funding News Edition: February 1, 2023
Successful offerors will help advance the research and development of promising candidate vaccines, therapeutics, and diagnostics for biodefense, emerging infectious diseases, and pandemic preparedness.
Check Out Career Development Opportunity for Early-Career Physician-Scientists
Funding News Edition: February 1, 2023
The Physician-Scientist Pathway to Independence Award is designed to increase and maintain the field of new and talented physician-scientists by supporting mentored research training and an independent research period.
Gain Support for Mentored Career Development Using Nonhuman Primate Models
Funding News Edition: February 1, 2023
By facilitating access to experienced mentors, relevant facilities, and protected time for training centered on nonhuman primate models, these awards will help early-career scientists address key issues in clinically relevant research areas.
December’s ACD Meeting—Featuring Bill Gates and Dr. Anthony Fauci
Funding News Edition: February 1, 2023
NIH’s Advisory Committee to the Director (ACD) provides recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.
NIAID Updates Interim R01, R03, and R21 Paylines
Funding News Edition: February 1, 2023
NIAID uses paylines as funding cutoff points for certain types of investigator-initiated grant applications. Last week, NIAID updated the interim paylines for research projects (R01), small grants (R03), and exploratory/developmental grants (R21).
NIH Shares Data on Investigators with Disabilities
Funding News Edition: February 1, 2023
To ensure a strong and diverse workforce and better understand workforce composition and participation in NIH programs, NIH regularly assesses the sex/gender, race, ethnicity,and disability status of its supported researchers.
Seek NIAID’s Help for an Investigator-Initiated Clinical Trial Application
Funding News Edition: February 1, 2023
NIAID strongly encourages consultations to apprise principal investigators of the time, cost, and regulatory obligations that come with seeking and receiving an investigator-initiated clinical trial award.
“What is the salary cap for a research project grant or cooperative agreement?”
Funding News Edition: February 1, 2023
“What demographic data does NIH collect on researchers via their eRA personal profile?”
Funding News Edition: February 1, 2023
Top Ten Things NIH RePORT and RePORTER Can Do for You
Funding News Edition: January 18, 2023
Use custom crafted queries to learn what active research projects represent the cutting edge of your field, find potential collaborators for future projects, and much more.
Contract Opportunity Renews NIAID Adjuvant Discovery Program
Funding News Edition: January 18, 2023
NIAID seeks to renew the Adjuvant Discovery Program, which supports the identification and characterization of novel, effective, and safe vaccine adjuvants.
New Solicitation Focuses on Development of Cellular Immunology Core
Funding News Edition: January 18, 2023
NIAID seeks a partner to operate the Cellular Immunology Core Laboratory, which will conduct, analyze, develop, optimize, and validate cellular immunologic assays for multiple pathogens, to be performed on fresh and frozen preclinical samples.
Reissued Supplements Provide Support for Early-Career Continuity
Funding News Edition: January 18, 2023
The funds may be used to pay for computational services, supplies, equipment, and supported effort of additional scientific staff to sustain the research project while an investigator gives priority to a critical life event.
Contact Us
Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.